Oct 29 (Reuters) - Vitrolife AB VITR.ST :
* INTERIM REPORT JANUARY - SEPTEMBER 2021: PROFITABLE GROWTH
AND
IGENOMIX ACQUISITION
* Q3 SALES AMOUNTED TO SEK 406 (320) MILLION, CORRESPONDING
TO AN
INCREASE OF 27 PERCENT IN SEK. SALES INCREASED BY 30 PERCENT IN
LOCAL CURRENCY.
* Q3 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION
(EBITDA) AMOUNTED TO SEK 162 (134) MILLION
* Q3 NET INCOME AMOUNTED TO SEK 105 (89) MILLION, WHICH GAVE
EARNINGS PER SHARE OF SEK 0.89 (0.81)
Source text for Eikon: ID:nWkr5dSYZJ
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))